From bluebird bio: FDA Accelerated Approval for SKYSONA® Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy
September 19, 2022
0
FDA Approves bluebird bio Product Skysona for Early, Active CALD SKYSONA is the first FDA approved …